{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:26:45Z","timestamp":1792520805786,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10787-025-01950-4","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:03:31Z","timestamp":1759399411000},"page":"6791-6803","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Boswellic acids as an adjunct therapy in Parkinson\u2019s disease: a double-blind clinical trial investigating on its effects on motor symptoms and inflammatory markers"],"prefix":"10.1007","volume":"33","author":[{"given":"Somayyeh","family":"Shateri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed Hossein","family":"Khatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Ehtiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Talebzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadegh","family":"Nikakhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monir Hassani","family":"Parvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Ozra","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamali","family":"Shahidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Habibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Salmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Namvarjah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Riazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Tafakhori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8233-4551","authenticated-orcid":false,"given":"Saeed","family":"Karima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"1950_CR1","doi-asserted-by":"publisher","first-page":"1347987","DOI":"10.3389\/fnagi.2024.1347987","volume":"16","author":"A Adamu","year":"2024","unstructured":"Adamu A, Li S, Gao F, Xue G (2024) The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front Aging Neurosci 16:1347987","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"1950_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed9010013","volume":"9","author":"AA Al-Qahtani","year":"2024","unstructured":"Al-Qahtani AA, Alhamlan FS, Al-Qahtani AA (2024) Pro-inflammatory and anti-inflammatory interleukins in infectious diseases: a comprehensive review. Trop Med Infect Dis 9(1):13. https:\/\/doi.org\/10.3390\/tropicalmed9010013","journal-title":"Trop Med Infect Dis"},{"issue":"6","key":"1950_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.5001\/omj.2011.101","volume":"26","author":"A Al-Saeed","year":"2011","unstructured":"Al-Saeed A (2011) Gastrointestinal and cardiovascular risk of nonsteroidal anti-inflammatory drugs. Oman Med J 26(6):385\u2013391. https:\/\/doi.org\/10.5001\/omj.2011.101","journal-title":"Oman Med J"},{"key":"1950_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/978-3-319-41334-1_13","volume":"928","author":"HP Ammon","year":"2016","unstructured":"Ammon HP (2016) Boswellic acids and their role in chronic inflammatory diseases. Adv Exp Med Biol 928:291\u2013327. https:\/\/doi.org\/10.1007\/978-3-319-41334-1_13","journal-title":"Adv Exp Med Biol"},{"key":"1950_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cells11182908","author":"B Ara\u00fajo","year":"2022","unstructured":"Ara\u00fajo B, Caridade-Silva R, Soares-Guedes C, Martins-Macedo J, Gomes ED, Monteiro S, Teixeira FG (2022) Neuroinflammation and Parkinson\u2019s disease-from neurodegeneration to therapeutic opportunities. Cells. https:\/\/doi.org\/10.3390\/cells11182908","journal-title":"Cells"},{"issue":"1","key":"1950_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41531-019-0097-1","volume":"5","author":"R Balestrino","year":"2019","unstructured":"Balestrino R, Hurtado-Gonzalez CA, Stocchi F, Radicati FG, Ray Chaudhuri K, Rodriguez-Blazquez C, Martinez-Martin P (2019) Applications of the European Parkinson\u2019s Disease Association sponsored Parkinson\u2019s Disease Composite Scale (PDCS). NPJ Parkinsons Dis 5(1):26","journal-title":"NPJ Parkinsons Dis"},{"issue":"6","key":"1950_CR7","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s10787-019-00627-z","volume":"27","author":"SM Baram","year":"2019","unstructured":"Baram SM, Karima S, Shateri S, Tafakhori A, Fotouhi A, Lima BS, Rajaei S, Mahdavi M, Tehrani HS, Aghamollaii V, Aghamiri SH, Mansouri B, Gharahje S, Kabiri S, Hosseinizadeh M, Shahamati SZ, Alborzi AT (2019a) Functional improvement and immune-inflammatory cytokines profile of ischaemic stroke patients after treatment with boswellic acids: a randomized, double-blind, placebo-controlled, pilot trial. Inflammopharmacology 27(6):1101\u20131112. https:\/\/doi.org\/10.1007\/s10787-019-00627-z","journal-title":"Inflammopharmacology"},{"key":"1950_CR8","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s10787-019-00627-z","volume":"27","author":"SM Baram","year":"2019","unstructured":"Baram SM, Karima S, Shateri S, Tafakhori A, Fotouhi A, Lima BS, Rajaei S, Mahdavi M, Tehrani HS, Aghamollaii V (2019b) Functional improvement and immune-inflammatory cytokines profile of ischaemic stroke patients after treatment with boswellic acids: a randomized, double-blind, placebo-controlled, pilot trial. Inflammopharmacology 27:1101\u20131112","journal-title":"Inflammopharmacology"},{"key":"1950_CR9","doi-asserted-by":"publisher","DOI":"10.1080\/19390211.2025.2468484","author":"S Barzin Tond","year":"2025","unstructured":"Barzin Tond S, Abolghasemi S, Khatami SH, Ehtiati S, Zarei T, Shateri S, Baram SM, Yarahmadi S, Fallah S, Salmani F (2025) Boswellic acids reduce systemic inflammation in patients with moderate COVID-19 through modulation of NF-\u03baB pathway. J Diet Suppl. https:\/\/doi.org\/10.1080\/19390211.2025.2468484","journal-title":"J Diet Suppl"},{"issue":"17","key":"1950_CR10","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.3390\/nu15173839","volume":"15","author":"ZK Bytowska","year":"2023","unstructured":"Bytowska ZK, Korewo-Labelle D, Kowalski K, Libionka W, Przew\u0142\u00f3cka K, Kloc W, Kaczor JJ (2023) Impact of 12 weeks of vitamin D3 administration in Parkinson\u2019s patients with deep brain stimulation on kynurenine pathway and inflammatory status. Nutrients 15(17):3839","journal-title":"Nutrients"},{"issue":"2","key":"1950_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/gps.4756","volume":"33","author":"N Carson","year":"2018","unstructured":"Carson N, Leach L, Murphy KJ (2018) A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores. Int J Geriatr Psychiatry 33(2):379\u2013388","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"1950_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.11606\/issn.1679-9836.v99i1p66-75","volume":"99","author":"JM da Cunha","year":"2020","unstructured":"da Cunha JM, de Siqueira EC (2020) O papel da neurocirurgia na doen\u00e7a de Parkinson: revis\u00e3o de literatura. Revista De Medicina 99(1):66\u201375","journal-title":"Revista De Medicina"},{"key":"1950_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59101756","author":"Y Degirmenci","year":"2023","unstructured":"Degirmenci Y, Angelopoulou E, Georgakopoulou VE, Bougea A (2023) Cognitive impairment in Parkinson\u2019s disease: an updated overview focusing on emerging pharmaceutical treatment approaches. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina59101756","journal-title":"Medicina (Kaunas)"},{"issue":"7","key":"1950_CR14","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1523\/jneurosci.3567-08.2009","volume":"29","author":"C D'Mello","year":"2009","unstructured":"D\u2019Mello C, Le T, Swain MG (2009) Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factor\u03b1 signaling during peripheral organ inflammation. J Neurosci 29(7):2089\u20132102. https:\/\/doi.org\/10.1523\/jneurosci.3567-08.2009","journal-title":"J Neurosci"},{"issue":"11","key":"1950_CR15","doi-asserted-by":"publisher","first-page":"7376","DOI":"10.4049\/jimmunol.180.11.7376","volume":"180","author":"R-N Dogan","year":"2008","unstructured":"Dogan R-N, Elhofy A, Karpus WJ (2008) Production of CCL2 by central nervous system cells regulates development of murine experimental autoimmune encephalomyelitis through the recruitment of TNF-and iNOS-expressing macrophages and myeloid dendritic cells. J Immunol 180(11):7376\u20137384","journal-title":"J Immunol"},{"key":"1950_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/v14112445","author":"NM Elemam","year":"2022","unstructured":"Elemam NM, Talaat IM, Maghazachi AA (2022) CXCL10 chemokine: a critical player in RNA and DNA viral infections. Viruses. https:\/\/doi.org\/10.3390\/v14112445","journal-title":"Viruses"},{"key":"1950_CR17","doi-asserted-by":"publisher","first-page":"2076942","DOI":"10.1155\/2020\/2076942","volume":"2020","author":"C Fang","year":"2020","unstructured":"Fang C, Lv L, Mao S, Dong H, Liu B (2020) Cognition deficits in Parkinson\u2019s Disease: mechanisms and treatment. Parkinsons Dis 2020:2076942. https:\/\/doi.org\/10.1155\/2020\/2076942","journal-title":"Parkinsons Dis"},{"issue":"1","key":"1950_CR18","doi-asserted-by":"publisher","first-page":"19796","DOI":"10.1038\/s41598-024-67165-9","volume":"14","author":"C Femiano","year":"2024","unstructured":"Femiano C, Bruno A, Gilio L, Buttari F, Dolcetti E, Galifi G, Azzolini F, Borrelli A, Furlan R, Finardi A, Musella A, Mandolesi G, Storto M, Centonze D, Bassi MS (2024) Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression. Sci Rep 14(1):19796. https:\/\/doi.org\/10.1038\/s41598-024-67165-9","journal-title":"Sci Rep"},{"issue":"1","key":"1950_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41531-018-0055-3","volume":"4","author":"JG Goldman","year":"2018","unstructured":"Goldman JG, Vernaleo BA, Camicioli R, Dahodwala N, Dobkin RD, Ellis T, Galvin JE, Marras C, Edwards J, Fields J, Golden R, Karlawish J, Levin B, Shulman L, Smith G, Tangney C, Thomas CA, Tr\u00f6ster AI, Uc EY, Coyan N, Ellman C, Ellman M, Hoffman C, Hoffman S, Simmonds D (2018) Cognitive impairment in Parkinson\u2019s disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health. NPJ Parkinsons Dis 4(1):19. https:\/\/doi.org\/10.1038\/s41531-018-0055-3","journal-title":"NPJ Parkinsons Dis"},{"key":"1950_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/bs11050074","author":"P Gonzalez-Latapi","year":"2021","unstructured":"Gonzalez-Latapi P, Bayram E, Litvan I, Marras C (2021) Cognitive impairment in Parkinson\u2019s disease: epidemiology, clinical profile, protective and risk factors. Behav Sci. https:\/\/doi.org\/10.3390\/bs11050074","journal-title":"Behav Sci"},{"key":"1950_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fnagi.2019.00229","volume":"11","author":"AL Gross","year":"2019","unstructured":"Gross AL, Walker KA, Moghekar AR, Pettigrew C, Soldan A, Albert MS, Walston JD (2019) Plasma markers of inflammation linked to clinical progression and decline during preclinical AD. Front Aging Neurosci 11:229","journal-title":"Front Aging Neurosci"},{"key":"1950_CR22","first-page":"11","volume":"2019","author":"AL Gross","year":"2023","unstructured":"Gross AL, Walker KA, Moghekar AR, Pettigrew C, Soldan A, Albert MS, Walston JD (2023) Plasma markers of inflammation linked to clinical progression and decline during preclinical AD. Front Aging Neurosci 2019:11","journal-title":"Front Aging Neurosci"},{"key":"1950_CR23","doi-asserted-by":"publisher","first-page":"878771","DOI":"10.3389\/fimmu.2022.878771","volume":"13","author":"A Grotemeyer","year":"2022","unstructured":"Grotemeyer A, McFleder RL, Wu J, Wischhusen J, Ip CW (2022) Neuroinflammation in Parkinson\u2019s disease\u2013putative pathomechanisms and targets for disease-modification. Front Immunol 13:878771","journal-title":"Front Immunol"},{"key":"1950_CR24","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.3389\/fimmu.2019.02759","volume":"10","author":"M Gschwandtner","year":"2019","unstructured":"Gschwandtner M, Derler R, Midwood KS (2019) More than just attractive: how CCL2 influences myeloid cell behavior beyond chemotaxis. Front Immunol 10:2759","journal-title":"Front Immunol"},{"issue":"1","key":"1950_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.34172\/PS.2020.25","volume":"27","author":"H Haghaei","year":"2020","unstructured":"Haghaei H, Soltani S, Hosseini SA, Rashidi MR, Karima S (2020) Boswellic acids as promising leads in drug development against Alzheimer\u2019s disease. Pharm Sci 27(1):14\u201331","journal-title":"Pharm Sci"},{"issue":"1","key":"1950_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/mdc3.12553","volume":"5","author":"SK Holden","year":"2018","unstructured":"Holden SK, Finseth T, Sillau SH, Berman BD (2018) Progression of MDS-UPDRS scores over five years in de novo Parkinson disease from the Parkinson\u2019s progression markers initiative cohort. Mov Disord Clin Pract 5(1):47\u201353. https:\/\/doi.org\/10.1002\/mdc3.12553","journal-title":"Mov Disord Clin Pract"},{"issue":"21","key":"1950_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/cells11213468","volume":"11","author":"C-T Hong","year":"2022","unstructured":"Hong C-T, Chan L, Chen K-Y, Lee H-H, Huang L-K, Yang Y-C, Liu Y-R, Hu C-J (2022b) Rifaximin modifies gut microbiota and attenuates inflammation in Parkinson\u2019s disease: preclinical and clinical studies. Cells 11(21):3468","journal-title":"Cells"},{"key":"1950_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cells11213468","author":"CT Hong","year":"2022","unstructured":"Hong CT, Chan L, Chen KY, Lee HH, Huang LK, Yang YSH, Liu YR, Hu CJ (2022a) Rifaximin modifies gut microbiota and attenuates inflammation in Parkinson\u2019s disease: preclinical and clinical studies. Cells. https:\/\/doi.org\/10.3390\/cells11213468","journal-title":"Cells"},{"key":"1950_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12938-021-00872-w","volume":"20","author":"MD Hssayeni","year":"2021","unstructured":"Hssayeni MD, Jimenez-Shahed J, Burack MA, Ghoraani B (2021) Ensemble deep model for continuous estimation of unified Parkinson\u2019s Disease Rating Scale III. Biomed Eng Online 20:1\u201320","journal-title":"Biomed Eng Online"},{"key":"1950_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells12071012","author":"S Isik","year":"2023","unstructured":"Isik S, Yeman Kiyak B, Akbayir R, Seyhali R, Arpaci T (2023) Microglia mediated neuroinflammation in Parkinson\u2019s disease. Cells. https:\/\/doi.org\/10.3390\/cells12071012","journal-title":"Cells"},{"issue":"1","key":"1950_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1615\/critrevimmunol.v32.i1.30","volume":"32","author":"SS Iyer","year":"2012","unstructured":"Iyer SS, Cheng G (2012) Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol 32(1):23\u201363. https:\/\/doi.org\/10.1615\/critrevimmunol.v32.i1.30","journal-title":"Crit Rev Immunol"},{"issue":"6","key":"1950_CR32","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1192\/bja.2019.79","volume":"26","author":"S Jones","year":"2020","unstructured":"Jones S, Torsney KM, Scourfield L, Berryman K, Henderson EJ (2020) Neuropsychiatric symptoms in Parkinson\u2019s disease: aetiology, diagnosis and treatment. Bjpsych Adv 26(6):333\u2013342","journal-title":"Bjpsych Adv"},{"issue":"5","key":"1950_CR33","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1007\/s10753-023-01853-y","volume":"46","author":"RA Kachouei","year":"2023","unstructured":"Kachouei RA, Doagoo A, Jalilzadeh M, Khatami SH, Rajaei S, Jahan-Abad AJ, Salmani F, Pakrad R, Baram SM, Nourbakhsh M (2023) Acetyl-11-keto-beta-boswellic acid has therapeutic benefits for NAFLD rat models that were given a high fructose diet by ameliorating hepatic inflammation and lipid metabolism. Inflammation 46(5):1966\u20131980","journal-title":"Inflammation"},{"issue":"9996","key":"1950_CR34","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386(9996):896\u2013912","journal-title":"Lancet"},{"issue":"1","key":"1950_CR35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3233\/JAD-221026","volume":"94","author":"S Karima","year":"2023","unstructured":"Karima S, Aghamollaii V, Mahmoodi Baram S, Balenci L, Lanct\u00f4t KL, Kiss A, Tafakhori A, Mahdavi M, Rajaei S, Shateri S (2023) Boswellic acids improve clinical cognitive scores and reduce systemic inflammation in patients with mild to moderate Alzheimer\u2019s disease. J Alzheimers Dis 94(1):359\u2013370","journal-title":"J Alzheimers Dis"},{"key":"1950_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-024-02176-2","author":"S Karima","year":"2024","unstructured":"Karima S, Khatami SH, Ehtiati S, Khoshtinatnikkhouy S, Ataei Kachouei R, Jahanbazi Jahan-Abad A, Tafakhori A, Firoozpour H, Salmani F (2024) Acetyl 11-keto beta-boswellic acid improves neurological functions in a mouse model of multiple sclerosis. Inflammation. https:\/\/doi.org\/10.1007\/s10753-024-02176-2","journal-title":"Inflammation"},{"key":"1950_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cellimm.2018.02.011","volume":"327","author":"MN Karpenko","year":"2018","unstructured":"Karpenko MN, Vasilishina AA, Gromova EA, Muruzheva ZM, Bernadotte A (2018) Interleukin-1\u03b2, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-\u03b1 levels in CSF and serum in relation to the clinical diversity of Parkinson\u2019s disease. Cell Immunol 327:77\u201382","journal-title":"Cell Immunol"},{"issue":"1","key":"1950_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40035-022-00280-7","volume":"11","author":"G Li","year":"2022","unstructured":"Li G, Huang P, Cui S-S, Tan Y-Y, He Y-C, Shen X, Jiang Q-Y, Huang P, He G-Y, Li B-Y (2022) Mechanisms of motor symptom improvement by long-term Tai Chi training in Parkinson\u2019s disease patients. Transl Neurodegener 11(1):6","journal-title":"Transl Neurodegener"},{"key":"1950_CR39","doi-asserted-by":"publisher","first-page":"105978","DOI":"10.1016\/j.parkreldis.2023.105978","volume":"120","author":"G Li","year":"2024","unstructured":"Li G, Huang P, Cui S, He Y, Jiang Q, Li B, Li Y, Xu J, Wang Z, Tan Y, Chen S (2024) Tai Chi improves non-motor symptoms of Parkinson\u2019s disease: one-year randomized controlled study with the investigation of mechanisms. Parkinsonism Relat Disord 120:105978. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105978","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"1950_CR40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41398-021-01349-z","volume":"11","author":"NM Lyra e Silva","year":"2021","unstructured":"Lyra e Silva NM, Gon\u00e7alves RA, Pascoal TA, Lima-Filho RAS, Fran\u00e7a Resende EdP, Vieira ELM, Teixeira AL, de Souza LC, Peny JA, Fortuna JTS, Furigo IC, Hashiguchi D, Miya-Coreixas VS, Clarke JR, Abisambra JF, Longo BM, Donato J, Fraser PE, Rosa-Neto P, Caramelli P, Ferreira ST, De Felice FG (2021) Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer\u2019s disease. Transl Psychiatry 11(1):251. https:\/\/doi.org\/10.1038\/s41398-021-01349-z","journal-title":"Transl Psychiatry"},{"issue":"1","key":"1950_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1176\/appi.focus.20160043","volume":"15","author":"J Mack","year":"2017","unstructured":"Mack J, Marsh L (2017) Parkinson\u2019s disease: cognitive impairment. Focus (Am Psychiatr Publ) 15(1):42\u201354. https:\/\/doi.org\/10.1176\/appi.focus.20160043","journal-title":"Focus (Am Psychiatr Publ)"},{"issue":"4","key":"1950_CR42","doi-asserted-by":"publisher","first-page":"288","DOI":"10.52547\/phypha.25.4.5","volume":"25","author":"N Marefati","year":"2021","unstructured":"Marefati N, Khamse S, Mansouri S, Hosseini M, Anaeigoudari A (2021) Effects of Boswellia serrata resin on central nervous system: a mini review. Physiol Pharmacol 25(4):288\u2013295","journal-title":"Physiol Pharmacol"},{"issue":"6","key":"1950_CR43","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009282","volume":"2","author":"P Mazzoni","year":"2012","unstructured":"Mazzoni P, Shabbott B, Cort\u00e9s JC (2012) Motor control abnormalities in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2(6):a009282. https:\/\/doi.org\/10.1101\/cshperspect.a009282","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"1950_CR44","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/02699052.2022.2059816","volume":"36","author":"S Meshkat","year":"2022","unstructured":"Meshkat S, Mahmoodi Baram S, Rajaei S, Mohammadian F, Kouhestani E, Amirzargar N, Tafakhori A, Shafiee S, Meshkat M, Balenci L (2022) Boswellia serrata extract shows cognitive benefits in a double-blind, randomized, placebo-controlled pilot clinical trial in individuals who suffered traumatic brain injury. Brain Inj 36(4):553\u2013559","journal-title":"Brain Inj"},{"key":"1950_CR45","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neubiorev.2016.07.010","volume":"68","author":"AA Moustafa","year":"2016","unstructured":"Moustafa AA, Chakravarthy S, Phillips JR, Gupta A, Keri S, Polner B, Frank MJ, Jahanshahi M (2016) Motor symptoms in Parkinson\u2019s disease: a unified framework. Neurosci Biobehav Rev 68:727\u2013740. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.07.010","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"1950_CR46","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3390\/antiox10020228","volume":"10","author":"M Muthu","year":"2021","unstructured":"Muthu M, Gopal J, Chun S, Devadoss AJP, Hasan N, Sivanesan I (2021) Crustacean waste-derived chitosan: antioxidant properties and future perspective. Antioxidants 10(2):228","journal-title":"Antioxidants"},{"key":"1950_CR47","doi-asserted-by":"publisher","first-page":"742065","DOI":"10.3389\/fnins.2021.742065","volume":"15","author":"L Muzio","year":"2021","unstructured":"Muzio L, Viotti A, Martino G (2021) Microglia in neuroinflammation and neurodegeneration: from understanding to therapy. Front Neurosci 15:742065","journal-title":"Front Neurosci"},{"issue":"10","key":"1950_CR48","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fneur.2019.00062","volume":"2019","author":"M Olson","year":"2019","unstructured":"Olson M, Lockhart TE, Lieberman A (2019a) Motor learning deficits in Parkinson\u2019s disease (PD) and their effect on training response in gait and balance: a narrative review. Front Neurol 2019(10):62","journal-title":"Front Neurol"},{"key":"1950_CR49","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fneur.2019.00062","volume":"10","author":"M Olson","year":"2019","unstructured":"Olson M, Lockhart TE, Lieberman A (2019b) Motor learning deficits in Parkinson\u2019s disease (PD) and their effect on training response in gait and balance: a narrative review. Front Neurol 10:62","journal-title":"Front Neurol"},{"issue":"11","key":"1950_CR50","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","volume":"73","author":"X-Y Qin","year":"2016","unstructured":"Qin X-Y, Zhang S-P, Cao C, Loh YP, Cheng Y (2016) Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis. JAMA Neurol 73(11):1316\u20131324","journal-title":"JAMA Neurol"},{"issue":"1","key":"1950_CR51","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41531-023-00449-5","volume":"9","author":"Yi Qu","year":"2023","unstructured":"Qu Yi, Li J, Qin Q, Wang D, Zhao J, An Ke, Mao Z, Min Z, Xiong Y, Li J, Xue Z (2023) A systematic review and meta-analysis of inflammatory biomarkers in Parkinson\u2019s disease. NPJ Parkinsons Dis 9(1):18. https:\/\/doi.org\/10.1038\/s41531-023-00449-5","journal-title":"NPJ Parkinsons Dis"},{"issue":"3","key":"1950_CR52","doi-asserted-by":"publisher","first-page":"277","DOI":"10.22038\/ijbms.2020.35288.8419","volume":"23","author":"A Rajabian","year":"2020","unstructured":"Rajabian A, Sadeghnia H, Fanoudi S, Hosseini A (2020) Genus Boswellia as a new candidate for neurodegenerative disorders. Iran J Basic Med Sci 23(3):277\u2013286. https:\/\/doi.org\/10.22038\/ijbms.2020.35288.8419","journal-title":"Iran J Basic Med Sci"},{"key":"1950_CR53","doi-asserted-by":"publisher","first-page":"121196","DOI":"10.1016\/j.lfs.2022.121196","volume":"312","author":"A Rajabian","year":"2023","unstructured":"Rajabian A, Farzanehfar M, Hosseini H, Arab FL, Nikkhah A (2023) Boswellic acids as promising agents for the management of brain diseases. Life Sci 312:121196. https:\/\/doi.org\/10.1016\/j.lfs.2022.121196","journal-title":"Life Sci"},{"issue":"3","key":"1950_CR54","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","volume":"10","author":"S Ramesh","year":"2023","unstructured":"Ramesh S, Arachchige A (2023) Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: a review of the literature. AIMS Neurosci 10(3):200\u2013231. https:\/\/doi.org\/10.3934\/Neuroscience.2023017","journal-title":"AIMS Neurosci"},{"key":"1950_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/480739","author":"G Ramesh","year":"2013","unstructured":"Ramesh G, MacLean AG, Philipp MT (2013) Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm. https:\/\/doi.org\/10.1155\/2013\/480739","journal-title":"Mediators Inflamm"},{"issue":"6","key":"1950_CR56","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1515\/revneuro-2015-0059","volume":"27","author":"A Saghazadeh","year":"2016","unstructured":"Saghazadeh A, Ferrari CC, Rezaei N (2016) Deciphering variability in the role of interleukin-1\u03b2 in Parkinson\u2019s disease. Rev Neurosci 27(6):635\u2013650","journal-title":"Rev Neurosci"},{"key":"1950_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-020-1608-8","volume":"20","author":"A Santaella","year":"2020","unstructured":"Santaella A, Bea Kuiperij H, van Rumund A, Esselink RAJ, van Gool AJ, Bloem BR, Verbeek MM (2020) Inflammation biomarker discovery in Parkinson\u2019s disease and atypical parkinsonisms. BMC Neurol 20:1\u20138","journal-title":"BMC Neurol"},{"key":"1950_CR58","first-page":"1555","volume":"2","author":"M Sastre","year":"2010","unstructured":"Sastre M, Gentleman SM (2010) NSAids: how they work and their prospects as therapeutics in Alzheimer\u2019s disease. Front Aging Neurosci 2:1555","journal-title":"Front Aging Neurosci"},{"key":"1950_CR59","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2023.2292951","author":"S Shateri","year":"2023","unstructured":"Shateri S, Khatami SH, Haghbin Toutounchi A, Rajaei S, Mahdavi M, Mahmoodi Baram S, Shahidi G-A, Habibi AH, Aghamollaii V, Ghlichnia B (2023) Plasma cytokines profile in patients with Alzheimer\u2019s and Parkinson\u2019s disease: a comparative study in terms of inflammation. Int J Neurosci. https:\/\/doi.org\/10.1080\/00207454.2023.2292951","journal-title":"Int J Neurosci"},{"issue":"3","key":"1950_CR60","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4103\/0250-474x.93507","volume":"73","author":"MZ Siddiqui","year":"2011","unstructured":"Siddiqui MZ (2011) Boswellia serrata, a potential antiinflammatory agent: an overview. Indian J Pharm Sci 73(3):255\u2013261. https:\/\/doi.org\/10.4103\/0250-474x.93507","journal-title":"Indian J Pharm Sci"},{"issue":"S2","key":"1950_CR61","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1002\/ana.21472","volume":"64","author":"T Simuni","year":"2008","unstructured":"Simuni T, Sethi K (2008) Nonmotor manifestations of Parkinson\u2019s disease. Ann Neurol 64(S2):S65\u2013S80","journal-title":"Ann Neurol"},{"issue":"4","key":"1950_CR62","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/mdc3.12476","volume":"4","author":"M Skorvanek","year":"2017","unstructured":"Skorvanek M, Martinez-Martin P, Kovacs N, Rodriguez-Violante M, Corvol J-C, Taba P, Seppi K, Levin O, Schrag A, Foltynie T (2017) Differences in MDS-UPDRS scores based on Hoehn and Yahr stage and disease duration. Mov Disord Clin Pract 4(4):536\u2013544","journal-title":"Mov Disord Clin Pract"},{"key":"1950_CR63","doi-asserted-by":"publisher","first-page":"111384","DOI":"10.1016\/j.exger.2021.111384","volume":"150","author":"F Soke","year":"2021","unstructured":"Soke F, Kocer B, Fidan I, Keskinoglu P, Guclu-Gunduz A (2021) Effects of task-oriented training combined with aerobic training on serum BDNF, GDNF, IGF-1, VEGF, TNF-\u03b1, and IL-1\u03b2 levels in people with Parkinson\u2019s disease: a randomized controlled study. Exp Gerontol 150:111384","journal-title":"Exp Gerontol"},{"issue":"1","key":"1950_CR64","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2174\/1871530323666230512154634","volume":"24","author":"N Solanki","year":"2024","unstructured":"Solanki N, Gupta G, Chellappan DK, Singh SK, Gulati M, Paudel KR, Hansbro PM, Dua K, Bhan S, Saini M, Dureja H (2024) Boswellic acids: a critical appraisal of their therapeutic and nutritional benefits in chronic inflammatory diseases. Endocr Metab Immune Disord Drug Targets 24(1):116\u2013129. https:\/\/doi.org\/10.2174\/1871530323666230512154634","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"11","key":"1950_CR65","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22(11):657\u2013673","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1950_CR66","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.13419","volume":"327","author":"B Tastan","year":"2024","unstructured":"Tastan B, Heneka MT (2024) The impact of neuroinflammation on neuronal integrity. Immunol Rev 327(1):8\u201332","journal-title":"Immunol Rev"},{"key":"1950_CR67","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3389\/fneur.2018.00860","volume":"9","author":"P Troncoso-Escudero","year":"2018","unstructured":"Troncoso-Escudero P, Parra A, Nassif M, Vidal RL (2018) Outside. In: unraveling the role of neuroinflammation in the progression of Parkinson\u2019s disease. Front Neurol 9:860","journal-title":"Front Neurol"},{"issue":"59","key":"1950_CR68","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1098\/rsif.2010.0456","volume":"8","author":"A Tsanas","year":"2011","unstructured":"Tsanas A, Little MA, McSharry PE, Ramig LO (2011) Nonlinear speech analysis algorithms mapped to a standard metric achieve clinically useful quantification of average Parkinson\u2019s disease symptom severity. J R Soc Interface 8(59):842\u2013855","journal-title":"J R Soc Interface"},{"issue":"19","key":"1950_CR69","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1212\/01.wnl.0000279519.99344.ad","volume":"69","author":"AD Wahner","year":"2007","unstructured":"Wahner AD, Bronstein JM, Bordelon YM, Ritz B (2007) Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease. Neurology 69(19):1836\u20131842. https:\/\/doi.org\/10.1212\/01.wnl.0000279519.99344.ad","journal-title":"Neurology"},{"issue":"1","key":"1950_CR70","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jstrokecerebrovasdis.2005.08.009","volume":"15","author":"CB Wright","year":"2006","unstructured":"Wright CB, Sacco RL, Rundek T, Delman J, Rabbani L, Elkind M (2006) Interleukin-6 is associated with cognitive function: the Northern Manhattan Study. J Stroke Cerebrovasc Dis 15(1):34\u201338. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2005.08.009","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"1950_CR71","first-page":"6734678","volume":"2016","author":"Y Yang","year":"2016","unstructured":"Yang Y, Tang B-S, Guo J-F (2016) Parkinson\u2019s disease and cognitive impairment. Parkinson\u2019s Dis 2016(1):6734678","journal-title":"Parkinson\u2019s Dis"},{"issue":"1","key":"1950_CR72","first-page":"28","volume":"6","author":"R Zaker","year":"2021","unstructured":"Zaker R, Beheshti S (2021) An updated review of the therapeutic anti-inflammatory effects of frankincense. Future Nat Prod 6(1):28\u201355","journal-title":"Future Nat Prod"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01950-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01950-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01950-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T23:02:58Z","timestamp":1763420578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01950-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":72,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1950"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01950-4","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"16 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or nonfinancial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The trial was conducted in accordance with the Declaration of Helsinki and was approved by the Shahid Beheshti University of Medical Sciences (SBMU) Ethics Committee (Reference number: IR.SBMU.MSP.REC.1395.603). All participants provided written informed consent before enrollment, and legal representatives were consulted when necessary. The study was conducted at a specialized neurology research center, with recruitment taking place over a 6-month period. The trial was also registered in the Iranian Registry of Clinical Trials (IRCT) under the identifier IRCT20170315033086N4. IRCT is a primary registry in the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP).\n                      \n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all the individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All the authors agreed on the final version of the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}